LifeVantage Corporation

LFVNNASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

12.5M

on 2026-06-30, from 12.7M on 2024-03-31 10-K ↗

Newest

$75.0M

S-3 of 2026-03-10. None sold under it to 2026-10-05. S-3 ↗

2 of its filings are not read yet.

Warrants

The 10-K filed 2026-08-27 is not read yet.

Cash

$14.9M

Operating cash flow was positive over the four quarters to 2026-06-30, so no quarters are counted. 10-K ↗

Raised: 3 of its filings are not read yet.